INMUNE BIO INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
INMUNE BIO INC. (INMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 50.00 thousand shares for the 1-month period ending 2020-07-31, per its 10-K filed 2022-03-03.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2022-03-03
- 2020-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 1 month 50.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 1 month |
|---|---|
| 2020-07-31 | 50.00K shares 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |